DailyTimeCapsule brief
April 25, 1968
On April 25, 1968, a significant breakthrough in medical science was reported as doctors endorsed a new drug for arthritis, promising relief for millions suffering from this debilitating condition. This event occurred during a period of social upheaval and change in America, marked by widespread protests against the Vietnam War and a burgeoning civil rights movement. Internationally, tensions were high as Israel firmly rejected a United Nations protest regarding its actions in the Middle East, reflecting the ongoing complexities of Middle Eastern geopolitics. In the United States, the media landscape was evolving, with journalism graduates being informed of a concerning pay-scale lag compared to other professions, raising questions about the value placed on journalistic integrity during a turbulent era of political reporting and public relations.
Key developments
-
During a recent hearing, Dr. Finals presented findings indicating that a certain arthritis drug is relatively safe for patient use, challenging earlier concerns. In contrast, Dr. W O'Brien had testified about the drug's potential dangers and ineffectiveness, raising questions about its approval. The pharmaceutical company Merck & Co subsequently issued a statement to clarify their position amidst the ongoing controversy.
-
In a critical announcement, G Kasturi from India highlighted the disparity in pay scales for journalism graduates compared to other professional groups. This issue came to light during discussions at the ANPA (American Newspaper Publishers Association) meeting, where it was suggested that the journalism field's financial recognition is lagging significantly. Kasturi also proposed the establishment of a global conference to strategize the creation of a world newsprint reserve, emphasizing the need for sustainable resources in journalism.
-
Israel Rejects U.N. Protest
